Search
Pazufloxacin
go.drugbank.com/drugs/DB11774InvestigationalPazufloxacin is under investigation in clinical trial NCT02592096 (Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol).
Categories: 4-Quinolones, Heterocyclic Compounds, 1-RingAllicin
go.drugbank.com/drugs/DB11780InvestigationalAllicin has been used in trials studying the treatment of Follicular Lymphoma.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 CYP3A InhibitorsBirinapant
go.drugbank.com/drugs/DB11782InvestigationalBirinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
Categories: Heterocyclic Compounds, 2-RingNeuropeptide Y
go.drugbank.com/drugs/DB11788ApprovedInvestigationalWithdrawnNeuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.
Categories: Neuropeptide Y, drug effectsSynonyms: Neuropeptide YPF-03882845
go.drugbank.com/drugs/DB11814InvestigationalPF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingTMC-647055
go.drugbank.com/drugs/DB11822InvestigationalTMC647055 has been used in trials studying the treatment of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, and Chronic Hepatitis C Virus.
Tofogliflozin
go.drugbank.com/drugs/DB11824InvestigationalTofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.
Categories: Sodium-Glucose Transporter 2 InhibitorsRuboxistaurin
go.drugbank.com/drugs/DB11829InvestigationalRuboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingCrenolanib
go.drugbank.com/drugs/DB11832InvestigationalCrenolanib is under investigation for the treatment of Diffuse Intrinsic Pontine Glioma and Progressive or Refractory High-Grade Glioma.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingLucitanib
go.drugbank.com/drugs/DB11845InvestigationalLucitanib has been used in trials studying the treatment of ER+, MBC, SCLC, HER2+, and NSCLC, among others.
Categories: Heterocyclic Compounds, 2-Ring